ORIGINAL RESEARCH
Published on 24 Jul 2025
Dynamic circulating tumor DNA indicates pathological benefits of additional neoadjuvant chemoimmunotherapy courses for locally advanced non-small-cell lung cancer patients
doi 10.3389/fonc.2025.1563315
- 435 views